Business / Finance

RSS
AstraZeneca selects Biologics as U.S. channel partner for vandetanib

AstraZeneca selects Biologics as U.S. channel partner for vandetanib

OCM announces acquisition of Diagnostics Plus

OCM announces acquisition of Diagnostics Plus

Alpine Access completes third party audit for compliance with HIPAA and HITECH Acts

Alpine Access completes third party audit for compliance with HIPAA and HITECH Acts

Pharmasset reports net loss of $19.9 million for quarter ended March 31, 2011

Pharmasset reports net loss of $19.9 million for quarter ended March 31, 2011

CareView closes $20 million financing with HealthCor

CareView closes $20 million financing with HealthCor

nSpire Health sales increase 3% to $27.6M for 2011

nSpire Health sales increase 3% to $27.6M for 2011

CHS issues statement in response to Tenet rejection of all-cash offer

CHS issues statement in response to Tenet rejection of all-cash offer

Saint Vincent Hospital to build new cancer center in downtown Worcester

Saint Vincent Hospital to build new cancer center in downtown Worcester

Novation adds BIOTRONIK to Cardiac Rhythm Management Devices portfolio

Novation adds BIOTRONIK to Cardiac Rhythm Management Devices portfolio

Tenet Healthcare board rejects revised undervalue proposal from Community Health Systems

Tenet Healthcare board rejects revised undervalue proposal from Community Health Systems

U.S. healthcare costs continue to increase at a declining rate

U.S. healthcare costs continue to increase at a declining rate

Creekridge Capital, Healthland partner to offer financing solutions for healthcare information system

Creekridge Capital, Healthland partner to offer financing solutions for healthcare information system

iMD to expand Medical Diagnostics operations

iMD to expand Medical Diagnostics operations

Cybex first quarter net sales increase 19% to $31.0 million

Cybex first quarter net sales increase 19% to $31.0 million

Valeant issues statement to shareholders of Cephalon

Valeant issues statement to shareholders of Cephalon

Cephalon files definitive Consent Revocation Statement, recommends shareholders to reject Valeant's proposals

Cephalon files definitive Consent Revocation Statement, recommends shareholders to reject Valeant's proposals

Prism Medical first quarter revenue increases 32% to $1.8 million

Prism Medical first quarter revenue increases 32% to $1.8 million

UHT net income is $4.1 million for quarter ended March 31, 2011

UHT net income is $4.1 million for quarter ended March 31, 2011

Endologix total revenue increases 28% to $18.5 million for first quarter 2011

Endologix total revenue increases 28% to $18.5 million for first quarter 2011

Sonomax net revenue decreases to $642,766 for year ended December 31, 2010

Sonomax net revenue decreases to $642,766 for year ended December 31, 2010

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.